Spero Therapeutics (SPRO) Cash from Financing Activities (2016 - 2023)
Spero Therapeutics (SPRO) posted Cash from Financing Activities of $1,000 for Q4 2023, down 100.0% from $14.18 million a year earlier and down 99.5% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Cash from Financing Activities (2016 - 2023) Analysis & Trends
For FY2023, Spero Therapeutics' Cash from Financing Activities came in at $221,000.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of -68.3% (FY2018 to FY2023).
- In prior years, Spero Therapeutics' Cash from Financing Activities was -$29.55 million in FY2022, $84.05 million in FY2021 (-35.8%), $130.88 million in FY2020 (+710.9%) and $16.14 million in FY2019 (-76.8%).
- The Q4 2023 figure stands as the lowest quarterly Cash from Financing Activities since Q2 2022.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q4 2021, with growth of 212.9%; the weakest was Q4 2023, with a decline of 100.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Spero Therapeutics | 63.77 Mn | -132.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 220,000.00 |
| Dec 31, 2022 | 14.18 Mn |
| Sep 30, 2022 | 6.13 Mn |
| Jun 30, 2022 | -53.68 Mn |
| Mar 31, 2022 | 3.81 Mn |
| Dec 31, 2021 | 50.35 Mn |
| Sep 30, 2021 | 29.22 Mn |
| Jun 30, 2021 | 168,000.00 |
| Mar 31, 2021 | 4.31 Mn |
| Dec 31, 2020 | 16.09 Mn |
| Sep 30, 2020 | 77.22 Mn |
| Jun 30, 2020 | 7.39 Mn |
| Mar 31, 2020 | 30.19 Mn |
| Dec 31, 2019 | 5.60 Mn |
| Sep 30, 2019 | 10,000.00 |
| Jun 30, 2019 | 8.96 Mn |
| Mar 31, 2019 | 1.57 Mn |
| Dec 31, 2018 | -178,000.00 |
| Sep 30, 2018 | 69.90 Mn |
API Access
Spero Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();